BA
CLB icon

Boston Advisors’s Core Laboratories CLB Stock Holding History

Boston Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,645
Closed -$439K – 650
2014
Q4 		$439K Sell
3,645
-200
-5% -$26.3K 0.02% 366
2014
Q3 		$563K Sell
3,845
-750
-16% -$116K 0.02% 330
2014
Q2 		$768K Buy
4,595
+100
+2% +$17.8K 0.03% 308
2014
Q1 		$892K Buy
4,495
+500
+13% +$94.4K 0.04% 282
2013
Q4 		$763K Buy
3,995
+50
+1% +$9.3K 0.04% 298
2013
Q3 		$668K Buy
3,945
+1,495
+61% +$232K 0.04% 296
2013
Q2 		$372K Buy
+2,450
New +$347K 0.02% 354

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Boston Advisors's CLB Position: Q1 2015 in Review

Boston Advisors sold out of Core Laboratories (CLB) in Q1 2015, closing a stake of 3,645 shares — an estimated $439K sold.

Boston Advisors first reported a position in CLB in Q2 2013 and held it in 7 quarters. The position peaked at $892K in Q1 2014. 347 funds tracked by Wall St. Rank hold CLB as of Q1 2015.

  • Boston Advisors reported no remaining Core Laboratories position as of Q1 2015 after selling out during the quarter.
  • Boston Advisors sold 3,645 Core Laboratories shares in Q1 2015, an estimated $439K.
  • Boston Advisors first reported a position in Core Laboratories in Q2 2013 and held it in 7 quarters.
  • Boston Advisors's Core Laboratories position peaked at $892K in Q1 2014.
  • 347 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2015.

Based on Boston Advisors's 13F filing for Q1 2015, filed 21 Apr 2015.